Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Friday, 26 April 2024 12:00 AM EOD	Asian-Paints2844.60	Axis-Bank1130.05	Bajaj-Finance6729.85	Bajaj-Finserv1597.10	Bharti-Airtel1325.50	HCL-Technologies1472.30	HDFC-Bank1509.75	Hind-Unilever2221.50	ICICI-Bank1107.15	IndusInd-Bank1445.85	Infosys1430.15	ITC439.95	JSW-Steel886.60	Kotak-Mah-Bank1608.40	Larsen-and-Toubro3602.30	M-and-M2044.25	Maruti-Suzuki12687.05	Nestle-India2483.80	NTPC355.75	Power-Grid-Corpn292.10	Reliance-Industr2903.00	St-Bk-of-India801.40	Sun-PharmaInds1504.25	Tata-Motors999.35	Tata-Steel165.85	TCS3812.85	Tech-Mahindra1277.45	Titan-Company3584.40	UltraTech-Cem9700.20	Wipro464.65
15 mins delay SENSEX 73,730.16 [-609.28]	-16.95 -0.59%	2.70 0.24%	-564.05 -7.73%	-58.70 -3.55%	-10.45 -0.78%	-31.35 -2.08%	-0.90 -0.06%	-9.50 -0.43%	-5.90 -0.53%	-50.30 -3.36%	-8.25 -0.57%	2.45 0.56%	-18.90 -2.09%	-34.60 -2.11%	-48.35 -1.32%	-51.30 -2.45%	-219.05 -1.70%	-78.90 -3.08%	-2.55 -0.71%	-1.00 -0.34%	-15.40 -0.53%	-11.20 -1.38%	-16.30 -1.07%	-1.45 -0.14%	-1.75 -1.04%	-39.00 -1.01%	87.35 7.34%	11.75 0.33%	16.60 0.17%	3.65 0.79%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Lupin gets US FDA nod to market generic version of osteoarthritis topical

22-Sep-22 15:22Hrs IST

The approved solution is a generic equivalent of Pennsaid Topical Solution of Horizon Pharma Ireland DAC.

Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID). Diclofenac topical (for the skin) is used to treat joint pain caused by osteoarthritis.

Diclofenac Sodium Topical Solution USP had estimated annual sales of USD 484 million in the U.S. (IQVIA MAT June 2022).

The product will be manufactured at Lupin's facility in Pithampur, India,” the company said in a statement.

Lupin is an innovation-led transnational pharmaceutical company. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

The drug maker reported a net loss of Rs 89.1 crore in Q1 FY23 as against a net profit of Rs 542.5 crore in Q1 FY22. Total revenue from operations declined 12.3% YoY to Rs 3,743.8 crore during the quarter.

Shares of Lupin rose 0.38% to Rs 663.70 on the BSE.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise